Literature DB >> 21208602

Structure, function and regulation of the melanocortin receptors.

Yingkui Yang1.   

Abstract

Melanocortin receptors belong to the seven-transmembrane (TM) domain proteins that are coupled to G-proteins and signaled through intracellular cyclic adenosine monophosphate. Many structural features conserved in other G-protein coupled receptors (GPCRs) are found in the melanocortin receptors. There are five melanocortin receptor subtypes and each of the melanocortin receptor subtypes has a different pattern of tissue expression and has its own profile regarding the relative potency of different melanocortin peptides. α-, β-, and γ-MSH and ACTH are known endogenous agonist ligands for the melanocortin receptors. Agouti and AgRP are the only known naturally occurring antagonists of the melanocortin receptors. We have examined the molecular basis of all five human melanocortin receptors for different ligand binding affinities and potencies using chimeric and mutated receptors. Our studies indicate that human melanocortin MC(1) receptor, human melanocortin MC(3) receptor, human melanocortin MC(4) receptor and human melanocortin MC(5) receptor utilize orthosteric sites for non selective agonists, α-MSH and NDP-α-MSH, high affinity binding and utilize allosteric sites for selective agonist or antagonist binding. Furthermore, our results indicate that molecular determinants of human melanocortin MC(2) receptor for ACTH binding and signaling are different from that of other melanocortin receptors. Many studies also indicate that agonists can induce different conformation changes of melanocortin receptors, which then lead to the activation of different signaling pathways, even when the expression level of receptor and the strength of stimulus-response coupling are the same. This finding may provide new information for the design of drugs for targeting melanocortin receptors.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21208602      PMCID: PMC3095696          DOI: 10.1016/j.ejphar.2010.12.020

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  44 in total

1.  Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats.

Authors:  J J Hwa; L Ghibaudi; J Gao; E M Parker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-08       Impact factor: 3.619

2.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

3.  Molecular pharmacology of neural melanocortin receptors.

Authors:  R A Adan; J Oosterom; R F Toonen; M V Kraan; J P Burbach; W H Gispen
Journal:  Receptors Channels       Date:  1997

4.  Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor.

Authors:  Y k Yang; C Dickinson; C Haskell-Luevano; I Gantz
Journal:  J Biol Chem       Date:  1997-09-12       Impact factor: 5.157

Review 5.  Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders.

Authors:  R A Adan; T Vink
Journal:  Eur Neuropsychopharmacol       Date:  2001-12       Impact factor: 4.600

6.  Molecular identification of the human melanocortin-2 receptor responsible for ligand binding and signaling.

Authors:  Min Chen; Charles J Aprahamian; Robert A Kesterson; Carroll M Harmon; Yingkui Yang
Journal:  Biochemistry       Date:  2007-09-18       Impact factor: 3.162

7.  The cloning of a family of genes that encode the melanocortin receptors.

Authors:  K G Mountjoy; L S Robbins; M T Mortrud; R D Cone
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

8.  Contribution of melanocortin receptor exoloops to Agouti-related protein binding.

Authors:  Y K Yang; C J Dickinson; Q Zeng; J Y Li; D A Thompson; I Gantz
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

9.  Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide.

Authors:  P Prusis; H B Schiöth; R Muceniece; P Herzyk; M Afshar; R E Hubbard; J E Wikberg
Journal:  J Mol Graph Model       Date:  1997-10       Impact factor: 2.518

Review 10.  Molecular modeling of melanocortin receptors.

Authors:  Hongmao Sun; David Fry
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

View more
  45 in total

1.  Functional melanocortin-2 receptors are expressed by mouse aorta-derived mesenchymal progenitor cells.

Authors:  Jodi F Evans; Anne Fernando; Louis Ragolia
Journal:  Mol Cell Endocrinol       Date:  2012-01-27       Impact factor: 4.102

Review 2.  Synaptic changes induced by melanocortin signalling.

Authors:  Vanni Caruso; Malin C Lagerström; Pawel K Olszewski; Robert Fredriksson; Helgi B Schiöth
Journal:  Nat Rev Neurosci       Date:  2014-02       Impact factor: 34.870

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal Melanoma.

Authors:  Narges K Tafreshi; Christopher J Tichacek; Darpan N Pandya; Michael L Doligalski; Mikalai M Budzevich; HyunJoo Kil; Nikunj B Bhatt; Nancy D Kock; Jane L Messina; Epifanio E Ruiz; Nella C Delva; Adam Weaver; William R Gibbons; David C Boulware; Nikhil I Khushalani; Ghassan El-Haddad; Pierre L Triozzi; Eduardo G Moros; Mark L McLaughlin; Thaddeus J Wadas; David L Morse
Journal:  J Nucl Med       Date:  2019-02-07       Impact factor: 10.057

5.  Systemic and local ACTH produced during inflammatory states promotes osteochondrogenic mesenchymal cell differentiation contributing to the pathologic progression of calcified atherosclerosis.

Authors:  Jodi F Evans; Louis Ragolia
Journal:  Med Hypotheses       Date:  2012-09-29       Impact factor: 1.538

Review 6.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

7.  Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice.

Authors:  Darren J Lee; Andrew W Taylor
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

Review 8.  Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes: sex differences in regulation of stress responsivity.

Authors:  Mario G Oyola; Robert J Handa
Journal:  Stress       Date:  2017-08-31       Impact factor: 3.493

9.  ACTH promotes chondrogenic nodule formation and induces transient elevations in intracellular calcium in rat bone marrow cell cultures via MC2-R signaling.

Authors:  Jodi F Evans; Sylvana Rodriguez; Louis Ragolia
Journal:  Cell Tissue Res       Date:  2013-01-29       Impact factor: 5.249

10.  Systematic Backbone Conformational Constraints on a Cyclic Melanotropin Ligand Leads to Highly Selective Ligands for Multiple Melanocortin Receptors.

Authors:  Minying Cai; Udaya Kiran Marelli; Jennifer Bao; Johannes G Beck; Florian Opperer; Florian Rechenmacher; Kaitlyn R McLeod; Morgan R Zingsheim; Lucas Doedens; Horst Kessler; Victor J Hruby
Journal:  J Med Chem       Date:  2015-08-11       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.